Hemorrhagic Bartholin's cyst in a woman using anti-platelet medication: A case report and review of the literature.

An 84-year-old postmenopausal female presented to our outpatient clinic with a chief complaint of painful swelling over her left vulva for several days. She had been taking clopidogrel (an antiplatelet medication, Sanofi Winthrop Ind., Ambares, France) for years. She denied recent fever or chills, trauma to the perineum, or previous surgical history of the perineum. She had a history of hypertension, diabetes mellitus, coronary artery disease (CAD) (three-vessel disease), chronic kidney disease (stage 3), and dementia. She had 4 children (all with vaginal deliveries). Her family history was unremarkable. Upon pelvic examination, a flesh-colored cystic nodule measuring approximately 2 cm × 3 cm on the left side of the vaginal vestibule was revealed. A Bartholin’s cyst was initially suspected. There was neither leukocytosis (white blood cell count: 8410/μL) nor an abnormal pattern regarding the differential count of the white blood cell. The C-reactive protein level (0.18 mg/dL) was also within normal limits. Prior to marsupialization, no coagulation profiles were checked. On postoperative day 9 (6 d after resuming taking clopidogrel), coagulation profiles were as follows: Platelet count: 193000/μL, prothrombin time: 11.6 s, and activated partial thromboplastin time: 27.7 s. All data regarding the coagulation profiles were within normal limits. No image examination was done.

A hemorrhagic Bartholin’s cyst was made after marsupialization.

No recurrence of the hemorrhagic Bartholin’s cyst was observed during the subsequent follow-ups for 6 mo.

Marsupialization of Bartholin’s cyst was performed smoothly. Local anesthesia with 1% xylocaine at the cyst region was performed. Then, an incision was made with a scalpel over the cystic wall to drain the fluid and relieve the pressure. After the incision, bleeding with some blood clots from the cyst was observed. The edges of the incision were then stitched (2-0 Vicryl) to create a small opening or “pouch” that allows the cyst to continue to drain into the vaginal cavity. Compression with gauze was applied to the area after creating the pouch to stop the bleeding, which ceased after several minutes of compression. Stopping the antiplatelet for 3 d was thus suggested. After the procedure, oral antibiotics with Ulex (1 st generation of cephalosporin) every 6 h were prescribed for 1 wk. The patient tolerated the procedures well. The postoperative condition of the hemorrhagic Bartholin cyst is illustrated in Figure 1 . Post-surgery condition of the hemorrhagic Bartholin’s cyst.

In addition to endometriomas of Bartholin’s cyst, hemorrhagic Bartholin’s cysts are rare events. We report the case of a postmenopausal female on an antiplatelet with a hemorrhagic Bartholin’s cyst who was successfully treated with marsupialization. No recurrence was observed during the 6-mo follow-up period. Older females taking antiplatelets should be cautious of bleeding when presenting with a Bartholin’s cyst.

Bartholin’s gland embryologically originates from the urogenital sinus and is supplied by the external pudendal artery[ 8 ]. When the Bartholin’s duct is obstructed, a Bartholin’s cyst forms, which is a chronic inflammatory condition[ 1 ]. Based on the concept that chronic inflammation promotes angiogenesis[ 9 , 10 ], Bartholin’s cysts would be hypervascularized and congested. Once an additional external force is present, Bartholin’s cysts might be prone to hemorrhage. In this case, the patient was bedridden and used a wheelchair. These conditions are thought to result in pressure sores[ 11 ]. Similarly, limited mobility would result in the exertion of an extra external force on Bartholin’s cyst, which would possibly make the cyst hemorrhagic. Additionally, the patient has been taking clopidogrel for secondary prevention of CAD. Clopidogrel binds irreversibly to the P2Y12 receptor on platelets and is a common antiplatelet medication for stroke or CAD. Bleeding is a common adverse effect of clopidogrel[ 12 , 13 ]. Reported risk factors for bleeding after clopidogrel use include age ≥ 75 years, concurrent use of other antiplatelets or anticoagulants, prolonged use for more than 6 mo, recent trauma or surgery[ 14 - 16 ]. The patient presented in this case was 84-years-old, had already taken clopidogrel for several years before the first outpatient visit, and was thought to be at an increased risk of bleeding events. Based on such conditions, the hemorrhagic Bartholin’s cyst might be expected. A Bartholin’s cyst is mainly a clinical diagnosis, which is based on detailed history taking and physical examinations[ 1 , 17 ]. In our case, the clinical presentation led to the impression of a Bartholin’s cyst. Thus, we did not arrange additional imaging examinations. The final diagnosis of a hemorrhagic Bartholin’s cyst was made after the surgical intervention. Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are useful tools for diagnosing a Bartholin’s cyst[ 18 , 19 ]. For example, on ultrasonography, Bartholin’s cyst is a centrally hypoechoic to the anechoic cystic lesion with a clearly defined wall[ 20 ]. On CT, the Bartholin’s cyst is typically presented as a round, fluid-attenuation, and non-enhancing cystic lesion. If the cyst contains hemorrhagic components, it will become hyperdense on CT[ 18 ]. About images on MRI, the Bartholin’s cyst is hyperintense on T2-weighted image, while it is hypointense without enhancement on T1-weighted image. For cysts containing hemorrhagic components, the content of the cyst becomes hypointense on T2-weighted images[ 18 , 21 ]. Although Bartholin’s cyst is usually diagnosed simply based on clinical clues, there might be cases that are difficult to be diagnosed clinically. For such a condition, clinicians could apply the above imaging examinations. A Bartholin’s cyst commonly contains clear mucus secreted from the Bartholin’s gland; in contrast, a Bartholin’s abscess is filled with turbid purulent secretions[ 22 ]. In this case, bright-red blood with some blood clots flew out from the cyst, which was unusual to us. Some cases of a hemorrhagic Bartholin’s cyst have been reported[ 19 , 23 - 25 ]. Details of these cases are summarized in Table 1 . Two of these cases (27-years-old and 39-years-old) were found to have a hematoma in Bartholin’s cyst soon after the Cesarean delivery, which was thought to be a possible postoperative complication[ 24 , 25 ]. The other cases (42-years-old, 46-years-old, and 68-years-old) were presented with straw-colored or dark-stained discharge from Bartholin’s cyst during the surgical procedure. The hemorrhagic component of the cyst was confirmed based on the pathological report in these cases[ 19 , 23 ]. The presentation of our case was quite different from those reported previously. Bright-red blood flowing out from the Bartholin’s cyst was encountered while making an incision on the cyst. Besides, our case did not undergo a surgical intervention of the perineum before the cyst appeared. Cases of the hemorrhagic Bartholin’s cyst DM: Diabetes mellitus; GA: Gestational age; IVF: In vitro fertilization; CS: Cesarean section; MRI: Magnetic resonance imaging. Apart from the above, the hemorrhagic Bartholin’s cyst should be differentiated from the endometriosis of the Bartholin’s gland[ 23 ]. Endometriosis is characterized by the estrogen-dependent proliferation of the endometrial gland and stroma at locations other than the uterine cavity. It generally occurs in females of childbearing age. Patients with endometriosis may develop infertility or cyclic pain[ 26 ]. Extrapelvic endometriosis is relatively uncommon compared to pelvic endometriosis[ 27 ]. However, endometriosis of the Bartholin’s gland is rarer. Only a few cases of endometriosis of the Bartholin’s gland have been reported. These cases were all of reproductive age. Cyclic vulvar pain or infertility was complained about in some of these patients[ 28 , 29 ]. Compared with these cases, our patient has been postmenopausal for several decades. The lesion on Bartholin’s gland did not appear long before the first outpatient clinic visit. As a result, we could differentiate the previously reported endometriosis of the Bartholin’s gland from the hemorrhagic Bartholin’s cyst presented in this study. There is still controversy regarding the best treatment of a Bartholin’s cyst[ 4 , 6 , 30 ]. I&D, fistulization with a Word catheter, marsupialization, and excision of the cyst are all commonly performed procedures[ 31 , 32 ]. I&D is the simplest way to treat Bartholin’s cyst, and it has the shortest recovery time due to its simplicity. However, the high recurrence rate is a shortcoming compared to other invasive treatments[ 3 ]. Word catheter fistulization is performed by placing the catheter into the incision wound of I&D, and then the balloon is inflated with 2 to 3 mL of saline. To ensure the future patency of the outflow tract, the catheter will remain in place for approximately 4 to 6 wk for the tract to be completely epithelialized[ 3 , 4 ]. Marsupialization is the preferred treatment for recurrent cases. An incision opens the cyst with a length of the entire cyst wall. After drainage and irrigation, the cyst wall and mucosa are sutured open with absorbable sutures by an interrupted method. Marsupialization could prevent the incision from closing and keep the duct patent for ongoing drainage[ 3 , 4 ]. Excision of the cyst is more commonly suggested in recurrent cases, patients aged over 40-years-old, or patients with lesions larger than 5 cm[ 4 ]. A previous study reported that none was superior to the others regarding recurrence rate[ 6 ]. Regarding complications following the above interventions, pain, hematoma, fever, scarring, and persistent dyspareunia were all reported. The above interventions generally had a comparable complication rate as the others, except the finding that marsupialization had an increased risk of persistent dyspareunia compared to excision of the cyst. But there was only limited evidence in this systematic review[ 6 ]. Among these interventions, fistulization with a Word catheter and marsupialization are the two most commonly applied procedures[ 31 , 33 ]. Previous studies reported that both interventions had comparable recurrence rates[ 31 , 33 ]. Also, a comparable postoperative complication rate was found among these two interventions[ 31 , 33 ]. Intriguingly, a recent retrospective cohort study by Karabük and Ganime Aygün[ 34 ] demonstrated that marsupialization had a significantly lower recurrence rate than fistulization with a Word catheter (8.3% vs 18.8%; P = 0.034). However, there was no statistical difference regarding comparing the postoperative complication rate among these two groups (marsupialization vs fistulization with a Word catheter: 5.3% vs 3.1%; P = 0.495; all presented with infection)[ 34 ]. For recurrent cases, cystectomy or marsupialization may be preferred[ 3 ]. However, there is limited evidence to compare these two procedures directly[ 6 ]. Because no single therapy has been proven to outweigh others, therapeutic plans should be personalized based on lesion size, presence of symptoms, or recurrence to prevent a future recurrence[ 6 , 34 ]. In a nutshell, our case demonstrated that marsupialization for a hemorrhagic Bartholin’s cyst was feasible. A limitation of this study is that only a single case was presented. Restricted generalizability should be considered. However, further evidence is required to confirm these hypotheses. In addition to endometriomas of Bartholin’s cyst, hemorrhagic Bartholin’s cysts are rare events. We report the case of a postmenopausal female on an antiplatelet medication with a hemorrhagic Bartholin’s cyst who was successfully treated with marsupialization. No recurrence was observed during the 6-mo follow-up period. Older females taking antiplatelets should be cautious of bleeding when presenting with a Bartholin’s cyst.

Bartholin’s glands, a pair of peanut-sized mucus-secreting glands, are located at the 4 and 8 o’clock of the vulva[ 1 ]. Mucous secretions drained via the Bartholin’s duct provide lubrication during intercourse and keep the vulva moist. When the drainage duct of the Bartholin’s gland is obstructed, a Bartholin’s cyst forms[ 1 ]. The lifetime risk of developing a Bartholin’s cyst is approximately 2%. It is predominantly observed in pre-menopausal women[ 2 ]. A Bartholin’s cyst is typically small and asymptomatic[ 3 , 4 ]. However, the cyst could become more significant or infected, forming an abscess. In such cases, perivulvar pain (while walking or sitting) and systemic symptoms (such as fever or chills) will be present. A giant cyst can obstruct the urethra and cause recurrent urinary tract infections[ 3 - 5 ]. Various management strategies in both outpatient and inpatient settings have been proposed to treat this disease effectively, including antibiotics, topical silver nitrate application, incision and drainage (I&D), fistulization, destruction, marsupialization, and total resection in refractory cases. Nevertheless, regardless of the management strategy selected, there is still a probability of recurrence[ 4 , 6 ]. Although Bartholin’s cyst is the most common lesion of the gland, several other lesions of the gland with either benign or malignant characteristics could be diagnosed[ 7 ]. This study reported the case of a postmenopausal female with a hemorrhagic Bartholin’s cyst, which was treated successfully with marsupialization. No recurrence was observed during the 6-mo follow-up period.